CSI Market
Sign In | Register

Volitionrx Limited (VNRX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VNRX Annual Cash Flow →
This cash flow overview for Volitionrx Limited spans from Jun 30 2025 to Jun 30 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-14.47
Depreciation & amortization0.78
Amortization of Other Assets0.87
Increase (Decrease) in Deferred Revenue-0.89
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation0.46
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-1.58
Common Stock Issued For Services-
Nonoperating Income Grants Received-
Stock And Warrants Issued During Period Value Preferred Stock And Warrants-
Amortization Of Operating Lease Right Of Use Assets-
Warrants Issued For Services-
Financing Costs For Warrants Modified-
Management And Directors Fees Payable-
Stock Granted During Period Value Sharebased Compensation-
Operating Lease Right Of Use Asset Amortization Expense0.05
Increase Decrease In Management And Directors Fees Payable-
Derivative Gain Loss On Derivative Net-0.10
Warrants Gain Loss On Warrants Net-
Net Gain Loss-
Increase Decrease In Management Fees Payable-
Increase Decrease In Operating Lease Liability-0.06
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.04
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.40
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.22
Other Working Capital0.14
Other Noncash Income (Expense)0.00
Other net-0.03
Payments for (Proceeds from) Other Operating Activities4.50
Discontinued operations0.00
Net Cash flow from Operating Activities-10.44
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.01
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.96
Long-term debt - repayments-0.03
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock11.01
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock1.76
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.02
Other net-1.09
Proceeds From Grants-
Proceeds From Reverse Merger-
Cash Acquired Through Reverse Merger-
Proceeds From Grants Received-
Capital Lease Funding-
Payments On Grants Repayable-
Proceeds From Grants Repayable-
Payments On Finance Lease Obligations-
Treasury Stock Value Acquired Cost Method-
Payments Of Grants Repable-
Adjustments Related To Tax Withholding For Share Based Compensations-
Common Stock Repurchased-
Common Stock Issued On Exercises Of Stock Options And Warrants And Settlements Of Rsus-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities12.60
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-10.45
Total Cash Flow1.67
4 historic quarters locked

Sign in to unlock the full Volitionrx Limited cash flow history.

Sign In Create Free Account

About Volitionrx Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: vnrx_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001477932-26-004995

Figures are derived from filed reports and may be restated. Historical data is subject to revision.